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Abstract	  
In	  the	  context	  of	  host-­‐pathogen	  interaction,	  host	  cell	  receptors	  and	  signaling	  pathways	  are	  
essential	   for	   both	   invading	   pathogens,	   which	   exploit	   them	   at	   their	   own	   profit,	   and	   the	  
defending	   organism,	   which	   activates	   early	   mechanism	   of	   defense,	   known	   as	   innate	  
immunity,	   to	   block	   the	   aggression.	   Because	   of	   their	   central	   role	   as	   scaffolding	   proteins	  
downstream	  of	  activated	  receptors,	  β-­‐arrestins	  are	   involved	   in	  multiple	  signaling	  pathways	  
activated	   in	   host	   cells	   by	   pathogens.	   Some	   of	   these	   pathways	   participate	   to	   the	   innate	  
immunity	   and	   the	   inflammatory	   response.	   Other	   β-­‐arrestin-­‐dependent	   pathways	   are	  
actually	   hijacked	   by	   microbes	   and	   toxins	   to	   penetrate	   into	   host	   cells	   and	   spread	   in	   the	  
organism.	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  response,	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  NF-­‐κB,	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meningococcus,	  blood-­‐brain	  barrier,	  Filoviridae,	  HTLV-­‐1,	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Host-­‐pathogen	   interactions	   are	   complex	   multi-­‐facet	   phenomena	   determining	   how	  
host	  cells	  are	  colonized	  and	  how	  pathogens	  can	  disseminate	  (Figure1).	  Intracellular	  bacteria,	  
viruses	  and	  microbial	  toxins	  penetrate	  into	  host	  cell	  after	  crossing	  plasma	  membranes.	  They	  
can	  then	  proliferate	  and/or	  spread	  to	   invade	  host	  tissues.	  Extracellular	  pathogens,	   instead,	  
need	   to	   cross	   the	  mechanical	   barrier	   constituted	   by	   skin,	   airways,	   gut,	   urinary,	   or	   genital	  
tract	  epithelia	  to	  diffuse	  to	  the	  bloodstream	  and	  colonize	  organs.	  Crossing	  the	  first	  layer	  of	  
epithelial	  cells	  and	  then	  endothelia	  can	  be	  achieved	  by	  different	  mechanisms.	  Pathogens	  can	  
pass	   through	   these	   barriers	   via	   endocytosis	   at	   their	   apical	   (for	   epithelia)	   or	   luminal	   (for	  
endothelia)	  side	  and	  then	  be	  shuttled	  inside	  vesicles	  to	  the	  basolateral	  side,	  a	  phenomenon	  
known	  as	   transcytosis.	   They	  can	  also	  disseminate	   through	   the	   intercellular	   space	  between	  
two	   adjacent	   cells	   via	   the	   so-­‐called	   paracellular	   route.	   Finally,	   they	   can	   first	   infect	   blood	  
cells,	  which	  are	  physiologically	  capable	  of	  crossing	  epithelia	  and	  endothelia	  (by	  diapedesis),	  
and	  carry	  the	  hidden	  pathogen	  on	  the	  other	  side	  of	  the	  barrier	  like	  a	  Troy	  horse.	  	  
In	  all	  these	  cases,	  early	  steps	  of	  infection	  usually	  require	  pathogen	  adhesion	  to	  host	  
cells	  via	  specific	  interaction	  with	  cell	  surface	  receptors.	  Then,	  pathogen	  binding	  to	  host	  cell	  
receptors	   induces	  signaling	  events	   leading	  to	   important	  changes	   in	  cell	  metabolism,	  shape,	  
organization,	   trafficking,	   which	   are	   exploited	   by	   the	   pathogen	   for	   proliferation	   and	  
productive	   infection.	   On	   the	   other	   hand,	   pathogens	  must	   circumvent	   host	   cell	   responses,	  
which	   induce	   signaling	   cascades	   leading	   to	   inflammation	   and	   other	   early	   mechanism	   of	  
defense	  known	  as	  innate	  immunity.	  Thus,	  in	  the	  context	  of	  host-­‐pathogen	  interaction,	  host	  
cell	   receptors	   and	   signaling	   pathways	   are	   essential	   for	   both	  pathogens	   and	   the	  defending	  
organism.	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1.	   Beta	  arrestins	   are	   multi-­‐task	   proteins,	   which	   regulate	   cell	   surface	   receptors	   and	  
orchestrate	  signaling	  pathways	  in	  time	  and	  space	  	  
Beta	  arrestins	  1	  and	  2	  (βarr1	   and	   βarr2,	   also	  named	  arrestin	  2	  and	  3)	   are	   the	   ubiquitous	  
isoforms	   of	   visual	   arrestin,	   which	   in	   the	   retinal	   tissue	   is	   responsible	   for	   the	   “arrest”	   of	  
rhodopsin	   activation.	   It	   is	   not	   surprising	   therefore,	   that	  βarrs	  were	   originally	   identified	   as	  
negative	   regulators	   of	   G	   protein-­‐coupled	   receptor	   (GPCR)	   function	   in	   non-­‐retinal	   tissues,	  
because	   their	   binding	   promotes	   GPCR	   desensitization	   (Lohse	   et	   al.	   1990).	   Indeed,	   the	  
translocation	   of	   cytoplasmic	   βarrs	   to	   activated	   and	   phosphorylated	   receptors	   uncouples	  
GPCRs	  from	  downstream	  G	  protein-­‐dependent	  signaling	  pathways.	  βarrs	  were	  subsequently	  
shown	  to	  play	  a	  role	  as	  adaptor	  proteins	  connecting	  activated	  and	  phosphorylated	  GPCRs	  to	  
AP2	   and	   clathrin,	   two	   components	   of	   the	   endocytic	   machinery	   (Goodman	   et	   al.	   1996;	  
Laporte	  et	  al.	  1999).	  Thank	  to	  this	  molecular	  bridge	  GPCRs	  are	  recruited	   in	  clarthin-­‐coated	  
pits	  and	  subsequently	   internalized	   into	  endosomes.	  Successive	   investigations	  extended	  the	  
spectrum	  of	  the	  roles	  of	  βarrs	  in	  receptor	  trafficking.	  Indeed,	  βarrs	  promote	  the	  recruitment	  
of	  ubiquitin	   ligases	  and	  thus	  participate	   in	   the	  agonist-­‐induced	  ubiquitylation	  of	   receptors,	  
which	  impact	  on	  their	  subcellular	  localization	  and	  stability.	  Ubiquitination,	  in	  addition	  to	  its	  
well-­‐known	  function	  in	  soluble	  protein	  proteasomal	  degradation,	  serves	  as	  a	  signal	  to	  recruit	  
ubiquitin-­‐binding	   domain-­‐containing	   proteins,	   for	   specific	   biological	   functions,	   such	   as	  
endocytosis	   or	   sorting	   to	   lysosomes	   (Chen	   and	   Sun	   2009).	   Mdm2	   was	   the	   first	   E3	   ligase	  
recognized	  as	  a	  βarr	  partner;	  by	  ubiquitilating	  βarrs,	   it	  provides	  a	   signal	  necessary	   for	   the	  
internalization	  of	  βarr-­‐bound	  GPCRs	  (Shenoy	  et	  al.	  2001).	  Other	  E3	  ligases,	  such	  as	  NEDD4	  or	  
AIP4,	  were	   instead	   reported	   to	  provide	  a	   lysosome	  sorting-­‐signal	   to	   internalized	   receptors	  
(Shenoy	   et	   al.	   2008;	   Marchese	   et	   al.	   2003).	   βarrs	   were	   also	   found	   to	   participate	   in	  
internalization	  or	  ubiquitylation	  (or	  both)	  of	  many	  non-­‐GPCR	  receptors	  or	  plasma	  membrane	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proteins:	  the	  type	  III	  transforming	  growth	  factor-­‐β	  receptor,	  the	  insulin-­‐like	  growth	  factor	  I	  
receptor,	  voltage-­‐dependent	  calcium	  channels,	  the	  Na(+)/H(+)	  exchangers	  NHE1	  and	  NHE5,	  
the	   vascular	   endothelial	   (VE)	   cadherin	   and	   Notch	   (reviewed	   in	   (Shukla	   et	   al.	   2011)).	  
Interestingly,	  recent	  studies	  have	  identified	  a	  larger	  and	  more	  ancient	  family	  of	  arrestin-­‐fold	  
proteins	   that	   display	   some	   structural	   similarity	   with	   βarrs	   and	   share	   their	   trafficking	   and	  
down-­‐regulating	   functions.	   This	   family	  of	   “α-­‐arrestins”	   is	   conserved	   in	  eukaryotes	   (Alvarez	  
2008)	   and	   comprises	   ARRDC	   (Arrestin	   domain-­‐containing)	   proteins	   (Nabhan	   et	   al.	   2010;	  
Patwari	  et	  al.	  2011)	   in	  mice	  and	  humans	  and	  ARTs	  (arrestin-­‐related	  trafficking	  adaptors)	   in	  
yeast	  (Lin	  et	  al.	  2008).	  
In	  addition	  to	  their	  role	  in	  receptor	  desensitization	  and	  trafficking,	  βarrs	  have	  a	  function	  
of	   signaling	   adaptors	   and	   scaffolds.	   Assembling	   signaling	   proteins	   into	  molecular	   hubs	   (or	  
signalosomes)	  constructed	  around	  scaffolding	  proteins	  is	  a	  common	  mechanism	  used	  by	  all	  
cells	  to	  correctly	  deliver	  specific	  signals	  in	  space	  and	  time	  (Good	  et	  al.	  2011).	  Since	  the	  first	  
description	  of	   the	   Ste5	   scaffold	   of	   the	  MAP	   kinase	   cascade	   in	   yeast	   (Choi	   et	   al.	   1994),	   an	  
increasing	  number	  of	  protein	  scaffolds	  have	  been	  identified,	  based	  on	  their	  ability	  of	  binding	  
multiple	  signaling	  partners	  via	  direct	  protein–protein	   interaction,	  due	  to	  their	  high	  content	  
of	   modular	   protein	   binding	   domains	   (Zeke	   et	   al.	   2009).	   After	   the	   pioneering	   report	  
describing	   the	   role	   of	   βarrs	   in	   organizing	   the	   oriented	   activation	   of	   MAP	   kinases	   in	   the	  
cytoplasm	   (McDonald	   et	   al.	   2000;	   Luttrell	   et	   al.	   2001),	   many	   other	   effector	   pathways	  
orchestrated	   by	  βarrs	   have	   been	   characterized	   (reviewed	   in	   (Shenoy	   and	   Lefkowitz	   2005;	  
Lefkowitz	   et	   al.	   2006;	   Kovacs	   et	   al.	   2009;	   Luttrell	   and	  Gesty-­‐Palmer	   2010))	   illustrating	   the	  
prominent	  role	  of	  βarrs	  in	  the	  control	  of	  cell	  signaling.	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2.	  βarrs	  in	  the	  host-­‐cell	  response	  to	  pathogens	  
Because	   of	   their	   central	   role	   as	   scaffolding	   proteins	   downstream	   of	   activated	  
receptors,	  βarrs	  are	  involved	  in	  multiple	  pathways	  activated	  in	  host	  cells	  by	  pathogens.	  The	  
important	   phenomenon	   of	  βarr-­‐dependent	   regulation	   of	   cell	  motility	   and	   chemotaxis,	   via	  
the	   control	   of	   actin	   polymerization	   and	   cytoskeletal	   rearrangements,	   will	   be	   treated	   in	  
another	   chapter	   of	   this	   book	   (ref	   to	   K.	   DeFea	   contribution).	   Here	   we	  will	   summarize	   the	  
principal	  established	  roles	  of	  βarrs	  in	  innate	  immunity,	  inflammatory	  response	  and	  apoptosis	  
(Table	  I).	  
	  
2.1.	  βarr	  involvement	  in	  leukocyte	  degranulation	  
The	   first	  evidence	   for	  a	  βarr	   involvement	   in	   innate	   immunity	  came	  from	  studies	  on	  
chemoattractant-­‐stimulated	   granule	   release	   in	   leukocytes	   (Barlic	   et	   al.	   2000).	   Leukocyte	  
granules	   contain	   several	   enzymes	   and	   non-­‐enzymatic	   compounds	   that	   participate	   in	  
bactericidal	   activity.	   The	   release	   of	   these	   granules	   is	   controlled	   by	   the	   activation	   of	   Fc	  
receptors	   or	  GPCRs	   for	   chemoattractants.	   Interleukin	   8	   (IL-­‐8)	   activation	   of	   the	   chemokine	  
receptor	   CXCR1	   was	   found	   to	   stimulate	   rapid	   formation	   of	   βarr	   complexes	   with	   the	   Src-­‐
family	   tyrosine	   kinases	   Hck	   or	   c-­‐Fgr.	   Hck	   association	   with	   βarrs	   activates	   the	   kinase	   and	  
allows	  its	  targeting	  to	  granules.	  In	  case	  of	  expression	  of	  dominant-­‐negative	  βarr	  mutant	  with	  
altered	   polyproline-­‐rich	   region	   (known	   to	   be	   critical	   for	   the	   interaction	   with	   the	   c-­‐Src	  
tyrosine	  kinase),	  granulocytes	  fail	  to	  release	  granules	  or	  activate	  tyrosine	  kinases	  in	  response	  
to	   IL-­‐8	   stimulation.	   Thus,	   in	   this	   pathophysiological	   context,	   βarrs	   are	   important	   signaling	  
molecules	  in	  the	  innate	  immune	  response.	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2.2.	  βarr	  regulation	  of	  Toll-­‐like	  receptor	  signaling	  	  
Pathogen-­‐associated	  molecular	   patterns	   (PAMPs)	   (Janeway	   1989)	   such	   as	   flagellin,	  
the	   lipopolysaccharide	   (LPS)	   or	   the	   peptidoglycan	   of	   bacterial	   cell	   wall	   are	   recognized	   by	  
specific	   host	   receptors	   known	   as	   pattern-­‐recognition	   receptors	   (PRRs).	   During	   infection,	  
PAMPs-­‐mediated	   activation	   of	   PRRs	   initiates	   inflammatory	   reactions,	  which	   constitute	   the	  
first	  line	  of	  defense	  and	  prepare	  the	  establishment	  of	  adaptative	  immune	  responses.	  Several	  
classes	   of	   PRRs	   have	   been	   described,	   among	   which	   the	   Toll-­‐like	   receptors	   (TLRs)	   are	   key	  
initiators	  of	  the	  innate	  immune	  response	  (Medzhitov	  et	  al.	  1997).	  Some	  TLRs	  (1,	  2,	  4,	  5,	  and	  
6)	  operate	  primarily	   at	   the	  plasma	  membrane	  whereas	  other	  TLRs,	  mostly	   involved	   in	   the	  
recognition	   of	   nucleic	   acids,	   are	   localized	   to	   late	   endosomes	   and	   lysosomes.	   Signal	  
transduction	  mechanisms	  of	  TLRs	  are	  similar	  to	  those	  elicited	  by	  some	  interleukin	  receptors.	  
TLRs	  contain	  a	  Toll	  interleukin-­‐1	  receptor	  homology	  (TIR)	  domain	  (O’Neill	  and	  Bowie	  2007),	  
which	   engage	   cytoplasmic	   TIR-­‐domain-­‐containing	   adaptors	   such	   as	   the	   myeloid	  
differentiation	   primary	   response	   gene	   88	   (MyD88),	   or	   the	   TIR	   domain	   containing	   adaptor	  
protein	   (TIRAP).	   These	   adaptors	   recruit	   members	   of	   the	   IRAK	   (IL-­‐1	   receptor–associated	  
kinase)	   family	   of	   serine-­‐threonine	   kinases	   that	   induce	   inflammatory	   cytokine	   expression.	  
MyD88	  and	  TIRAP	  promote	  the	  expression	  of	  nuclear	  factor	  NF-­‐kB-­‐dependent	  cytokines	  via	  
the	   activation	   of	   NFκB	   and	   of	  mitogen-­‐activated	   protein	   kinases,	   whereas	   other	   adaptors	  
induce	  the	  expression	  of	  type	  I	  interferons	  (IFNs).	  	  
The	   first	   indication	   that	   βarrs	   can	   modulate	   TLR	   signaling	   was	   based	   on	   the	  
observation	  that	  βarr2	  (not	  βarr1)	  directly	  interacts	  with	  IkBα	  	  (Gao	  et	  al.	  2004).	  The	  protein	  
kinase	   IKK,	   activated	   by	   phosphorylation	   downstream	   of	   stimulated	   TLRs	   or	   the	   TNF	  
receptor,	   phosphorylates	   IκBα	   that	   normally	   binds	   to	   the	   transcription	   factor	   NF-­‐κB	   and	  
	   7	  
inhibits	   its	  nuclear	   translocation.	  Once	  phosphorylated,	   IκBα	   is	   ubiquitinated	  and	   targeted	  
for	   degradation	   by	   the	   proteasome,	   releasing	   NF-­‐κB.	   NF-­‐κB-­‐containing	   heterodimers	   then	  
translocate	   into	   the	   nucleus	   and	   mediate	   the	   transcription	   of	   a	   vast	   array	   of	   proteins	  
involved	   in	   immune	   and	   inflammatory	   responses.	   Interaction	   with	   βarr2	   prevents	   the	  
phosphorylation	   and	   degradation	   of	   IκBα.	   Interestingly,	   GPCR	   stimulation	   can	   enhance	  
βarr2-­‐IκBα	  interaction	  and	  consecutive	  stabilization	  of	  IκBα,	  leading	  to	  the	  inhibition	  of	  the	  
NF-­‐κB	  pathway.	  Supporting	  the	  hypothesis	  that	  βarrs	  are	  negative	  regulators	  of	  the	   innate	  
immune	   activation	   via	   TLRs,	   it	   was	   reported	   that	   both	  βarr	   isoforms	   interact	   with	   TRAF6	  
preventing	   its	   auto-­‐ubiquitination	   and	   subsequent	   activation	  of	  NF-­‐κB	   (Wang	  et	   al.	   2006).	  
TRAF6	   is	   a	   ring	   domain	   E3	   ubiquitin	   ligase	   that	   it	   is	   involved	   in	   the	   activation	   of	   IKK	  
downstream	  of	  TLRs	  and	   IL-­‐1	  receptor;	   it	   interacts	  with	  βarrs	  upon	  stimulation	  by	   IL1-­‐β	  or	  
gram-­‐negative	   bacteria	   lipopolysaccharide.	   Consistently,	   endotoxin-­‐treated	   βarr2-­‐deficient	  
mice	   had	   higher	   expression	   of	   pro-­‐inflammatory	   cytokines	   were	   more	   susceptible	   to	  
endotoxin	  shock	  than	  controls.	  A	  subsequent	  study	  comparing	  wild	  type	  and	  βarr2-­‐deficient	  
mice	   confirmed	   that	   βarr2	   is	   a	   negative	   regulator	   of	   the	   inflammatory	   response	   in	  
polymicrobial	  sepsis	  (Fan	  et	  al.	  2010).	  However,	  the	  existence	  of	  different	  functional	  outputs	  
in	   mice	   models	   investigated	   with	   diverse	   experimental	   approaches	   (Porter	   et	   al.	   2010),	  
indicate	  a	  more	  complex	  regulation	  of	  TLRs	  response	  by	  βarrs.	  Part	  of	  the	  explanation	  might	  
be	   that	   βarr1	   and	   βarr2	   differentially	   regulate	   TLR	   signaling	   and	   pro-­‐inflammatory	   gene	  
expression.	  For	  example,	  one	  study	  reported	  that	  both	  βarrs	  negatively	  regulate	  LPS-­‐induced	  
NFκB,	  whereas	  only	  βarr2	  mediates	  LPS-­‐induced	  ERK	  1/2	  activation	  (Fan	  et	  al.	  2007).	  Also,	  in	  
a	  report	  examining	  adenovirus-­‐vector-­‐induced	  innate	  immune	  responses	  and	  involving	  TLR-­‐
dependent	   pathways,	   βarr1	   was	   found	   to	   be	   a	   positive	   regulator	   and	   βarr2	   a	   negative	  
regulator	   (Seregin	   et	   al.	   2010).	   The	   functional	   output	   of	   the	   specific	   involvement	   of	   each	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βarr	   isoform	  might	  also	  vary	   in	  different	  cell	   types.	   In	  macrophages,	  both	  βarr1	  and	  the	  G	  
protein	  receptor	  kinase	  GRK5	  inhibit	  LPS-­‐dependent	  signaling	  of	  the	  TLR4.	  More	  specifically,	  
βarr1	  (not	  βarr2)	  modulates	  the	  MAP	  kinase	  arm	  of	  TLR4	  signaling	  by	  interacting	  with	  NFκB1	  
p105,	   which	   is	   the	   precursor	   of	   NFκB1	   p50	   and	   a	   cytoplasmic	   inhibitor	   of	   NF-­‐κB:	   p105	  
functions	  as	  an	  IκB	  and	  retains	  associated	  p50	  in	  the	  cytoplasm.	  As	  described	  in	  fibroblasts	  
for	  βarr2,	  which	  directly	  interacts	  with	  IkBα	  preventing	  its	  phosphorylation	  and	  degradation	  
(Gao	  et	  al.	  2004),	  βarr1	  stabilizes	  p105.	  Knockdown	  of	  βarr1	  leads	  to	  enhanced	  LPS-­‐induced	  
phosphorylation	  and	  degradation	  of	  p105,	  enhanced	  MAP3K	  release,	  and	  enhanced	  MAP2K	  
phosphorylation	  (Parameswaran	  et	  al.	  2006).	  	  
In	  addition	  to	  its	  role	  in	  the	  inflammatory	  response	  via	  the	  NFκB	  and	  the	  MAP	  kinase	  
pathways,	  TLR4	  activation	  can	  promote	  apoptosis	  under	  certain	  conditions	  and	  in	  some	  cell	  
types	   (Gay	   and	  Gangloff	   2007).	   A	   recent	   study	   identified	   the	   glycogen	   synthase	   kinase-­‐3b	  
(GSK-­‐3b)	   as	   an	   intermediate	   for	   TL4-­‐mediated	   apoptosis	   (Li	   et	   al.	   2010).	   Interestingly,	   the	  
apoptotic	  cascade	  was	  attenuated	  by	  βarr2,	   likely	  via	   the	  stabilization	  of	  phospho-­‐GSK-­‐3b,	  
an	  inactive	  form	  of	  GSK-­‐3b.	  
	  
2.3.	  βarr	  regulation	  of	  natural	  killer	  cells.	  
Natural	   killer	   (NK)	   cells	   are	   critical	   components	   of	   the	   innate	   immune	   system	   that	  
recognize	   and	   kill	   tumor	   or	   virus-­‐infected	   target	   cells.	   These	   cells	   express	   at	   their	   surface	  
two	  sets	  of	  receptors.	  Activating	  receptors	  that	  are	  involved	  in	  the	  killing	  activity	  of	  NK	  cells,	  
whereas	  inhibitory	  receptors	  contribute	  to	  tolerance	  to	  normal	  healthy	  cells.	  The	  association	  
of	  the	  inhibitory	  receptor	  KIR2DL1	  with	  with	  βarr2	  was	  reported	  to	  induce	  the	  recruitment	  
of	   the	   tyrosine	   phosphatases	   SHP-­‐1	   and	   SHP-­‐2	   to	   KIR2DL1,	   contributing	   to	   the	   inhibitory	  
signaling.	  Cytotoxicity	  of	  NK	  cells	  is	  consequently	  higher	  in	  βarr2-­‐deficient	  mice	  and	  inhibited	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in	  animals	  overexpressing	  βarr2.	  The	  inhibitory	  effect	  of	  βarr2	  is	  functionally	  relevant	  in	  vivo,	  
as	   shown	   by	   decreased	   NK	   cell-­‐dependent	   susceptibility	   to	   cytomegalovirus	   infection	   in	  
βarr2-­‐deficient	  mice	  (Yu	  et	  al.	  2008).	  
	  
3.	   Receptors	   and	   signaling	   pathways	   involving	  βarrs	   that	   are	   hijacked	   by	  microbes	   and	  
toxins	  to	  penetrate	  into	  host	  cells	  or	  spread	  (Table	  II).	  
	  
3.1.	  Bacteria	  
Streptococcus	   pneumoniae	   (pneumococcus),	   a	   gram-­‐positive	   pathogen	   causing	  
pneumonia,	  sepsis	  and	  meningitis,	  is	  the	  first	  reported	  example	  of	  bacteria	  exploiting	  βarrs	  
for	   tissue	   invasion.	   Pneumococci	   translocate	   across	   human	   endothelial	   cells	   through	  
vesicular	  structures	  without	  intracellular	  multiplication	  (transcytosis).	  Early	  studies	  identified	  
the	  receptor	  for	  platelet-­‐activating	  factor	  (PAF)	  as	  the	  pneumococcus	  adhesion	  receptor	   in	  
both	  epithelial	   and	  endothelial	   cells	   (Cundell	   et	   al.	   1995;	  Ring	  et	   al.	   1998).	  Pneumococcus	  
binding	   to	  PAF	   receptors	   induces	  βarr	   translocation	  and	  endocytosis	  of	  pathogen-­‐receptor	  
complexes.	   Cytoplasmic	   activation	   of	   ERK,	   presumably	  mediated	   by	   βarrs,	   is	   required	   for	  
pneumococcal	   endocytosis	   (Radin	   et	   al.	   2005).	   Interestingly,	   instead	   of	   being	   directed	   to	  
lysosomes	  or	  recycled	  to	  the	  cell	  surface	  as	  agonist-­‐bound	  receptors,	  a	  significant	  proportion	  
of	  bacteria-­‐PAF	  receptor	  complexes	  are	  diverted	  to	  basolateral	  membranes,	  this	  proportion	  
being	   enhanced	   by	   βarr	   overexpression.	   Thus,	   pneumococci	   subvert	   the	   βarr-­‐dependent	  
trafficking	   machinery	   of	   PAF-­‐receptors	   to	   drive	   pathogen-­‐containing	   vacuoles	   away	   from	  
lysosomes	  and	  across	  endothelial	  cell	  barriers	  (Radin	  et	  al.	  2005).	  	  
	   N.	   meningitidis	   (meningococcus)	   is	   a	   Gram-­‐negative	   diplococcus	   causing	  
cerebrospinal	  meningitis	  and	  “purpura	  fulminans”,	  a	  severe	  disseminated	  form	  of	   infection	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with	   peripheral	   vascular	   leakage,	   ischemic	   tissue	   damage	   and	   septic	   shock.	   The	   ability	   of	  
meningococci	   to	   interact	  with	   endothelial	   cells	   is	   essential	   in	  meningococcal	   pathogenesis	  
(Coureuil	   et	   al.	   2012).	   After	   initial	   attachment,	   mediated	   by	   a	   still	   unidentified	   receptor,	  
bacteria	   have	   the	   ability	   to	   resist	   blood	   flow,	   to	  multiply	   and	   form	  micro-­‐colonies	   on	   the	  
apical	   surface	   of	   endothelial	   cells.	   The	   stabilization	   of	   bacterial	   colonies	   depends	   on	   the	  
formation	  of	  host	  cell	  protrusions,	  which	  occur	  in	  response	  to	  signaling	  cascades	  elicited	  by	  
the	   pathogen	   in	   the	   endothelial	   cells.	   In	   addition,	   bacterial-­‐induced	   signaling	   eventually	  
results	  in	  the	  opening	  of	  intercellular	  junctions	  with	  subsequent	  meningeal	  colonization	  via	  
the	  paracellular	   route	   (Coureuil	   et	   al.	   2009).	   It	   has	  been	  established	   that	   signaling	   in	  host	  
cells	   is	  provoked	  by	  polymeric	   filaments	   found	  on	  many	  Gram-­‐negative	  bacteria,	  known	  as	  
type	  IV	  pili,	  which	  correspond	  to	  the	  multimeric	  assembly	  of	  various	  pilin	  subunits	   (Miller	  et	  
al.	  2012).	  Recently,	  it	  was	  reported	  that	  N.meningitidis	  pilins	  allosterically	  stimulate	  a	  biased	  
β2-­‐adrenoceptor-­‐βarr	   signaling	   pathway	   in	   endothelial	   cells,	   which	   ultimately	   traps	  βarrs	  
and	   their	   interacting	   partners,	   such	   as	   the	   Src	   tyrosine	   kinase	   and	   junctional	   proteins	   VE-­‐
cadherin	   and	   p120,	   under	   bacterial	   colonies	   (Coureuil	   et	   al.	   2010).	   The	   cytoskeletal	  
reorganization	  mediated	   by	  βarr-­‐activated	   Src	   stabilizes	   bacterial	   adhesion	   to	   endothelial	  
cells	  under	  permanent	   flow,	  whereas	  βarr-­‐dependent	  delocalization	  of	   junctional	  proteins	  
results	  in	  anatomical	  gaps	  between	  adjacent	  endothelial	  cells,	  which	  are	  used	  by	  bacteria	  to	  
penetrate	   into	   tissues.	   The	   bacterial	   ligand,	   which	   activates	   the	   β2-­‐adrenoceptor	   by	  
interacting	  with	  the	  receptor	  N-­‐terminal	  region,	  corresponds	  to	  two	  particular	  components	  
of	  the	  pili,	  namely	  the	  pilins	  PilE	  and	  PilV.	  	  
N	   gonorrheae	   (gonococcus)	   a	   close relative of meningococcus, which most often cause 
isolated infection of the genito-urinary tract but can, in rare cases, spread into the 
bloodstream and colonize meninges (Martín et al. 2008), elicits similar signaling events as N 
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meningitidis in endothelial cells (Coureuil	  et	  al.	  2010). In addition, many	  other	  bacteria	  take	  
advantage	  of	  host	  cell	  signaling	  pathways	  involving	  Src	  activation	  and	  its	  substrate	  cortactin	  
to	   invade	   tissues,	   as	   in	   the	   case	  of	  Neisseria	   species.	   Although	  not	   investigated	   yet,	  βarrs	  
might	  well	  participate	  in	  the	  signaling	  pathways	  induced	  by	  these	  other	  pathogens.	  
	  
3.2.	  Viruses	  
	   Marburg	  virus	  (MARV)	  and	  Ebola	  virus	  (EBOV),	  two	  members	  of	  the	  Filoviridae	  family,	  
are	  the	  causative	  agents	  of	  a	  deadly	  infection,	  known	  as	  viral	  hemorrhagic	  fever	  (Schnittler	  
and	   Feldmann	   2003).	   Although	   several	   monocyte,	   macrophage,	   dendritic	   and	   endothelial	  
cell	  surface	  proteins	  have	  been	  implicated	  in	  filovirus	  entry,	  a	  common	  receptor,	  the	  T-­‐cell	  
immunoglobulin	   and	  mucin	   domain	   1	   (TIM-­‐1),	   was	   reported	   for	   both	   Ebola	   and	  Marburg	  
viruses	   (Kondratowicz	   et	   al.	   2011).	   Following	   viral	   glycoprotein	   (GP)-­‐dependent	   receptor	  
binding,	  filoviruses	  are	  internalized	  by	  clathrin-­‐mediated	  endocytosis.	  The	  cellular	  endocytic	  
machinery	  sorts	  internalized	  viruses	  to	  an	  acidic	  endosomal	  compartment,	  which	  is	  the	  site	  
of	   virus-­‐cell	   membrane	   fusion.	   A	   recent	   report	   examined	   the	   specific	   requirements	   for	  
different	   components	  of	   the	   clathrin	  endocytic	  machinery	   in	   Ebola	  GP	  versus	  Marburg	  GP	  
pseudovirion	  entry	  (Bhattacharyya	  et	  al.	  2011).	  Whereas	  Ebola	  GP	  pseudovirions	  specifically	  
required	   the	   adaptor	   proteins	   Eps15	   and	   AP-­‐2	   to	   be	   connected	   to	   clathrin,	   Marburg	   GP	  
pseudovirions	  specifically	  necessitated βarr1	  and	  the	  adaptor	  protein	  AP-­‐1	  instead	  of	  AP-­‐2.	  
Knocking	  down βarr1	  significantly	  delayed	  virus	  fusion	  with	  no	  evident	  virus-­‐binding	  defect.	  
 The	  endosomal	  sorting-­‐complex	  required	  for	  transport	  (ESCRT)	  machinery	  comprises	  
multiprotein	   complexes	   (ESCRT	   0–III)	   that	   cooperate	   in	   a	   sequential	   and	   a	   coordinated	  
manner	  to	  target	  ubiquitinated	  membrane	  cargo	  into	  vesicles	  that	  bud	  into	  late	  endosomes	  
to	  form	  multivesicular	  bodies	  (MVBs)	  (Hurley	  and	  Emr	  2006).	   In	  particular,	   internalized	  cell	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surface	  receptors	  that	  are	  programmed	  for	  lysosomal	  degradation	  are	  delivered	  to	  MVBs	  via	  
this	   machinery.	   Internalized	   ubiquitinated	   receptors	   in	   the	   endosomes	   are	   initially	  
recognized	   by	   ESCRT-­‐0,	   which	   subsequently	   recruits	   ESCRT-­‐I	   to	   endosomal	   membranes,	  
followed	  by	  recruitment	  of	  ESCRT	  II	  and	  III.	  The	  process	  terminates	  with	  receptor	  sorting	  into	  
budding	  intra-­‐endosomal	  vesicles	  (Raiborg	  and	  Stenmark	  2009).	  For	  some	  receptors,	  such	  as	  
the	  chemokine	  receptor	  CXCR4,	  βarr1	  connects	  the	  ubiquitinated	  receptor	  with	  ESCRT-­‐0	  and	  
regulates	   the	   amount	   of	   CXCR4	   that	   is	   degraded	   (Malik	   and	   Marchese	   2010).	   ESCRT	  
machinery	  also	  plays	  a	  key	  role	   in	  the	  budding	  of	  many	  enveloped	  viruses,	   including	  HIV-­‐1	  
and	  other	   retroviruses.	  Recently,	   it	  was	   reported	   that	  ARRDC	   (Arrestin	  domain-­‐containing)	  
proteins	   are	   involved	   in	  budding	  of	  murine	   leukemia	   virus	  or	   human	  T-­‐cell	   leukemia	   virus	  
type	  1	  by	  interacting	  with	  HECT	  ubiquitin	  ligases	  and	  promoting	  ESCRT-­‐III	  recruitment	  (Rauch	  
and	  Martin-­‐Serrano	  2011).	  	  
	  
3.3.	  Toxins	  
	  Bacillus	  anthracis,	  the	  bacterium	  responsible	  for	  the	  anthrax	  disease	  produces	  the	  anthrax	  
toxin,	  which	   is	   composed	  of	   three	   independent	  polypeptide	   chains.	   Two	  proteins	  have	   an	  
enzymatic	   activity	   (calmodulin	   dependent	   adenylate	   cyclase	   and	   metalloprotease,	   claving	  
the	  MAP	  kinase	  kinase,	  respectively)	  the	  third	  one	  being	  required	  for	  the	  translocation	  of	  the	  
two	  enzymes	  into	  the	  cytoplasm	  where	  their	  activity	  produces	  the	  toxic	  effects	  (Young	  and	  
Collier	  2007).	  The	  protein	   involved	   in	   toxin	   translocation,	  known	  as	   the	  protective	  antigen	  
(PA),	   interacts	   with	   the	   target	   cells.	   It	   is	   processed	   by	   host	   cell	   proteases,	   such	   as	   furin,	  
leading	   to	   the	   formation	  of	  a	  63kDa	   fragment	   that	  heptamerizes	   into	  a	   ring	   like	  structure.	  
The	   complex	  between	   the	  heptamer	  and	   the	   two	  enzymes	   is	   internalized	   into	  endosomes	  
where	   the	   heptamer	   forms	   a	   pore	   allowing	   the	   partially	   unfolded/activated	   enzymes	   to	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cross	   the	   endosomal	  membranes	   and	   reach	   the	   cytosol	   (Collier	   2009).	  Heptamerization	  of	  
the	   63kDa	   PA	   fragment	   leads	   to	   the	   activation	   of	   src-­‐like	   kinases	   (Abrami	   et	   al.	   2010b),	  
which	   phosphorylate	   the	   cytoplasmic	   tail	   of	   capillary	   morphogenesis	   2	   (CMG2)	   a	   type-­‐I	  
membrane	  protein	  that	  serves	  as	  toxin	  receptor.	  Toxin	  receptors	  (CMG2	  and	  also	  the	  tumor	  
endothelial	  marker	  8	  TEM8)	  are	  ubiquitinated,	   via	  a	  process	   that	   requires	  βarr1.	  Receptor	  
modification	   finally	   allows	   the	   recruitment	   of	   AP-­‐1	   adaptin	   and	   clathrin,	   leading	   to	   their	  
internalization	  via	  clathrin-­‐coated	  pits	  (Abrami	  et	  al.	  2010a).	  	  
	  
4.	  Conclusions	  and	  Perspectives	  
Facing	   the	   vast	   array	   of	   pathogen	   ligands	   and	   of	   potential	   host	   cell	   receptors	   that	  
have	   been	   selected	   by	   pathogens	   to	   penetrate	   into	   host	   cells	   or	   to	   cross	   epithelial	   and	  
endothelial	  barriers,	  the	  number	  of	  cellular	  pathways	  hijacked	  by	  pathogens	  or	  employed	  by	  
host	   cells	   as	   primary	   defense	   line	   are	   relatively	   limited.	   Moreover,	   a	   restricted	   set	   of	  
proteins	   such	   as	   kinases	   (Src	   family,	   MAP	   kinases),	   proteins	   involved	   in	   endocytosis	   and	  
sorting,	   junctional	   proteins,	   signaling	   adaptors	   at	   the	   cross-­‐road	   of	   various	   pathways	  
downstream	   of	   TLRs	   or	   cytokine	   receptors,	   is	   constantly	   involved	   in	   these	   processes,	  
whatever	   the	   type	   of	   the	   pathogen.	   Most	   of	   these	   proteins	   appear	   as	   direct	   or	   indirect	  
interactors	   of	   arrestins,	   suggesting	   that	   our	   current	   knowledge	   of	   the	   role	   of	   arrestins	   in	  
host-­‐pathogen	  interactions	  only	  represents	  the	  tip	  of	  the	  iceberg.	  	  
A	  remarkable	  feature	  of	  βarrs,	   is	  the	  large	  number	  of	  cellular	  proteins	  they	  interact	  
with,	  contrasting	  with	  limited	  amino-­‐acid	  residues	  and	  areas	  of	  contact	  involved	  in	  individual	  
interactions	  (Gurevich	  and	  Gurevich	  2012).	  This	  feature	  might	  be	  exploited	  to	  develop	  very	  
specific	  molecules	  capable	  of	  targeting	  signaling	  pathways	  at	  the	  appropriate	  level	  and	  with	  
exquisite	   precision	   for	   therapeutic	   purposes.	   In	   this	   context,	   host-­‐pathogen	   interactions	  
	   14	  




Abrami	   L,	   Bischofberger	  M,	   Kunz	  B,	  Groux	  R,	   van	  der	  Goot	   FG	   (2010a)	   Endocytosis	   of	   the	  
anthrax	   toxin	   is	   mediated	   by	   clathrin,	   actin	   and	   unconventional	   adaptors.	   PLoS	  
pathogens	  6:e1000792.	  
Abrami	  L,	  Kunz	  B,	  van	  der	  Goot	  FG	  (2010b)	  Anthrax	  toxin	  triggers	  the	  activation	  of	  src-­‐like	  
kinases	  to	  mediate	  its	  own	  uptake.	  Proc	  Natl	  Acad	  Sci	  USA	  107:1420-­‐1424.	  
Alvarez	  CE	  (2008)	  On	  the	  origins	  of	  arrestin	  and	  rhodopsin.	  BMC	  Evol	  Biol	  8:222.	  
Barlic	   J,	  Andrews	   JD,	  Kelvin	  AA,	  Bosinger	   SE,	  DeVries	  ME,	  Xu	   L,	  Dobransky	  T,	   Feldman	  RD,	  
Ferguson	   SS,	   Kelvin	   DJ	   (2000)	   Regulation	   of	   tyrosine	   kinase	   activation	   and	   granule	  
release	  through	  beta-­‐arrestin	  by	  CXCRI.	  Nat	  Immunol	  1:227-­‐233.	  
Bhattacharyya	  S,	  Hope	  TJ,	  Young	  JA	   (2011)	  Differential	   requirements	   for	  clathrin	  endocytic	  
pathway	   components	   in	   cellular	   entry	   by	   Ebola	   and	   Marburg	   glycoprotein	  
pseudovirions.	  Virology	  419:1-­‐9.	  
Chen	  ZJ,	  Sun	  LJ	   (2009)	  Nonproteolytic	   functions	  of	  ubiquitin	   in	  cell	   signaling.	  Mol	  Cell:275-­‐
286.	  
Choi	  KY,	  Satterberg	  B,	  Lyons	  DM,	  Elion	  EA	  (1994)	  Ste5	  tethers	  multiple	  protein	  kinases	  in	  the	  
MAP	  kinase	  cascade	  required	  for	  mating	  in	  S.	  cerevisiae.	  Cell	  78:499-­‐512.	  
Collier	  RJ	  (2009)	  Membrane	  translocation	  by	  anthrax	  toxin.	  Mol	  Aspects	  Med	  30:413-­‐422.	  
Coureuil	   M,	   Join-­‐Lambert	   O,	   Lecuyer	   H,	   Bourdoulous	   S,	   Marullo	   S,	   Nassif	   X	   (2012)	  
Mechanism	  of	  meningeal	  invasion	  by	  Neisseria	  meningitidis.	  Virulence	  3:164-­‐172.	  
	   15	  
Coureuil	  M,	  Lécuyer	  H,	  Scott	  MGH,	  Boularan	  C,	  Enslen	  H,	  Soyer	  M,	  Mikaty	  G,	  Bourdoulous	  S,	  
Nassif	   X,	   Marullo	   S	   (2010)	   Meningococcus	   hijack	   a	   ß2-­‐adrenoceptor-­‐ß-­‐arrestin	  
pathway	  to	  cross	  brain	  microvasculature	  endothelium.	  .	  Cell	  143:1149-­‐1160	  	  
Coureuil	  M,	  Mikaty	  G,	  Miller	  F,	  Lecuyer	  H,	  Bernard	  C,	  Bourdoulous	  S,	  Dumenil	  G,	  Mege	  RM,	  
Weksler	   BB,	   Romero	   IA,	   Couraud	   PO,	   Nassif	   X	   (2009)	   Meningococcal	   type	   IV	   pili	  
recruit	  the	  polarity	  complex	  to	  cross	  the	  brain	  endothelium.	  Science	  325:83-­‐87.	  
Cundell	   DR,	   Gerard	   NP,	   Gerard	   C,	   Idanpaan-­‐Heikkila	   I,	   Tuomanen	   EI	   (1995)	   Streptococcus	  
pneumoniae	  anchor	  to	  activated	  human	  cells	  by	  the	  receptor	  for	  platelet-­‐activating	  
factor.	  Nature	  377:435-­‐438.	  
Fan	  H,	  Bitto	  A,	  Zingarelli	  B,	  Luttrell	  LM,	  Borg	  K,	  Halushka	  PV,	  Cook	  JA	  (2010)	  Beta-­‐arrestin	  2	  
negatively	  regulates	  sepsis-­‐induced	  inflammation.	  Immunology	  130:344-­‐351.	  
Fan	  H,	  Luttrell	  LM,	  Tempel	  GE,	  Senn	  JJ,	  Halushka	  PV,	  Cook	  JA	  (2007)	  Beta-­‐arrestins	  1	  and	  2	  
differentially	   regulate	  LPS-­‐induced	  signaling	  and	  pro-­‐inflammatory	  gene	  expression.	  
Molecular	  immunology	  44:3092-­‐3099.	  
Gao	  H,	  Sun	  Y,	  Wu	  Y,	  Luan	  B,	  Wang	  Y,	  Qu	  B,	  Pei	  G	  (2004)	  Identification	  of	  beta-­‐arrestin2	  as	  a	  
G	   protein-­‐coupled	   receptor-­‐stimulated	   regulator	   of	   NF-­‐kappaB	   pathways.	  Mol	   Cell	  
14:303-­‐317.	  
Gay	  NJ,	  Gangloff	  M	  (2007)	  Structure	  and	  Function	  of	  Toll	  Receptors	  and	  Their	  Ligands.	  Annu	  
Rev	  Biochem	  76:141-­‐165.	  
Good	   MC,	   Zalatan	   JG,	   Lim	  WA	   (2011)	   Scaffold	   proteins:	   hubs	   for	   controlling	   the	   flow	   of	  
cellular	  information.	  Science	  332:680-­‐686.	  
Goodman	  OBJ,	  Krupnick	  JG,	  Santini	  F,	  Gurevich	  VV,	  Penn	  RB,	  Gagnon	  AW,	  Keen	  JH,	  Benovic	  
JL	   (1996)	   ß-­‐arrestin	   acts	   as	   a	   clathrin	   adaptor	   in	   endocytosis	   of	   the	   ß2-­‐adrenergic	  
receptor.	  Nature	  383:447-­‐450.	  
	   16	  
Gurevich	   VV,	   Gurevich	   EV	   (2012)	   Synthetic	   biology	   with	   surgical	   precision:	   targeted	  
reengineering	  of	  signaling	  proteins.	  Cell	  Signal	  24:1899-­‐1908.	  
Hurley	  JH,	  Emr	  SD	  (2006)	  The	  ESCRT	  complexes:	  Structure	  and	  mechanism	  of	  a	  membrane-­‐
trafficking	  network	  
.	  Annu	  Rev	  Biophys	  Biomol	  Struct	  35:277–298.	  
Janeway	  CA	  (1989)	  Approaching	  the	  asymptote?	  Evolution	  and	  revolution	  in	  immunology.	  .	  
Cold	  Spring	  Harbor	  Symposia	  on	  Quantitative	  Biology	  54:1-­‐13	  	  
Kondratowicz	  AS,	  Lennemann	  NJ,	  Sinn	  PL,	  Davey	  RA,	  Hunt	  CL,	  Moller-­‐Tank	  S,	  Meyerholz	  DK,	  
Rennert	  P,	  Mullins	  RF,	  Brindley	  M,	  Sandersfeld	  LM,	  Quinn	  K,	  Weller	  M,	  McCray	  PB,	  
Jr.,	  Chiorini	  J,	  Maury	  W	  (2011)	  T-­‐cell	  immunoglobulin	  and	  mucin	  domain	  1	  (TIM-­‐1)	  is	  
a	   receptor	   for	   Zaire	   Ebolavirus	   and	   Lake	   Victoria	  Marburgvirus.	   Proc	   Natl	   Acad	   Sci	  
USA	  108:8426-­‐8431.	  
Kovacs	   JJ,	   Hara	   MR,	   Davenport	   CL,	   Kim	   J,	   Lefkowitz	   RJ	   (2009)	   Arrestin	   development:	  
emerging	   roles	   for	   beta-­‐arrestins	   in	   developmental	   signaling	   pathways.	   Dev	   Cell	  
17:443-­‐458.	  
Laporte	  SA,	  Oakley	  RH,	  Zhang	  J,	  Holt	  JA,	  Ferguson	  SS,	  Caron	  MG,	  Barak	  LS	  (1999)	  The	  beta2-­‐
adrenergic	   receptor/betaarrestin	   complex	   recruits	   the	   clathrin	   adaptor	  AP-­‐2	  during	  
endocytosis.	  Proc	  Natl	  Acad	  Sci	  U	  S	  A	  96:3712-­‐3717.	  
Lefkowitz	  RJ,	  Rajagopal	  K,	  Whalen	  EJ	  (2006)	  New	  roles	  for	  beta-­‐arrestins	  in	  cell	  signaling:	  not	  
just	  for	  seven-­‐transmembrane	  receptors.	  Mol	  Cell	  24:643-­‐652.	  
Li	  H,	   Sun	  X,	   LeSage	  G,	   Zhang	  Y,	   Liang	  Z,	  Chen	   J,	  Hanley	  G,	  He	   L,	   Sun	  S,	   Yin	  D	   (2010)	  beta-­‐
arrestin	   2	   regulates	   Toll-­‐like	   receptor	   4-­‐mediated	   apoptotic	   signalling	   through	  
glycogen	  synthase	  kinase-­‐3beta.	  Immunology	  130:556-­‐563.	  
	   17	  
Lin	   CH,	   MacGurn	   JA,	   Chu	   T,	   Stefan	   CJ,	   Emr	   SD	   (2008)	   Arrestin	   related	   ubiquitin-­‐ligase	  
adaptors	  regulate	  endocytosis	  and	  protein	  turnover	  at	  the	  cell	  surface.	  Cell	  135:714–
725.	  
Lohse	  MJ,	  Benovic	  JL,	  Codina	  J,	  Caron	  MG,	  Lefkowitz	  RJ	  (1990)	  beta-­‐Arrestin:	  a	  protein	  that	  
regulates	  beta-­‐adrenergic	  receptor	  function.	  Science	  248:1547-­‐1550.	  
Luttrell	   LM,	   Gesty-­‐Palmer	   D	   (2010)	   Beyond	   desensitization:	   physiological	   relevance	   of	  
arrestin-­‐dependent	  signaling.	  Pharmacol	  Rev	  62:305-­‐330.	  
Luttrell	   LM,	   Roudabush	   FL,	   Choy	   EW,	  Miller	  WE,	   Field	  ME,	   Pierce	   KL,	   Lefkowitz	   RJ	   (2001)	  
Activation	   and	   targeting	   of	   extracellular	   signal-­‐regulated	   kinases	   by	   beta-­‐arrestin	  
scaffolds.	  Proc	  Natl	  Acad	  Sci	  U	  S	  A	  98:2449-­‐2454.	  
Malik	   R,	   Marchese	   A	   (2010)	   Arrestin-­‐2	   Interacts	   with	   the	   Endosomal	   Sorting	   Complex	  
Required	  for	  Transport	  Machinery	  to	  Modulate	  Endosomal	  Sorting	  of	  CXCR4.	  Mol	  Biol	  
Cell	  21:2529-­‐2541.	  
Marchese	  A,	  Raiborg	  C,	  Santini	  F,	  Keen	  JH,	  Stenmark	  H,	  Benovic	   JL	   (2003)	  The	  E3	  ubiquitin	  
ligase	   AIP4	  mediates	   ubiquitination	   and	   sorting	   of	   the	   G	   protein-­‐coupled	   receptor	  
CXCR4.	  Dev	  Cell	  5:709-­‐722.	  
Martín	  MC,	  Pérez	  F,	  Moreno	  A,	  Moral	  A,	  Alvarez	  MA,	  Méndez	  FJ,	  Vázquez	  F	  (2008)	  Neisseria	  
gonorrhoeae	  meningitis	  in	  pregnant	  adolescent.	  Emerg	  Infect	  Dis	  14:672-­‐674.	  
McDonald	   PH,	   Chow	   CW,	  Miller	  WE,	   Laporte	   SA,	   Field	  ME,	   Lin	   FT,	   Davis	   RJ,	   Lefkowitz	   RJ	  
(2000)	  Beta-­‐arrestin	  2:	  a	  receptor-­‐regulated	  MAPK	  scaffold	  for	  the	  activation	  of	  JNK3.	  
Science	  290:1574-­‐1577.	  
Medzhitov	  R,	  Preston-­‐Hurlburt	  P,	  Janeway	  CA	  (1997)	  A	  human	  homologue	  of	  the	  Drosophila	  
Toll	  protein	  signals	  activation	  of	  adaptive	  immunity.	  Nature	  388:394–397.	  
	   18	  
Miller	  F,	  Lecuyer	  H,	   Join-­‐Lambert	  O,	  Bourdoulous	  S,	  Marullo	  S,	  Nassif	  X,	  Coureuil	  M	  (2012)	  
Neisseria	  meningitidis	  colonization	  of	  the	  brain	  endothelium	  and	  cerebrospinal	  fluid	  
invasion.	  Cellular	  microbiology.	  
Nabhan	  JF,	  Pan	  H,	  Lu	  Q	  (2010)	  Arrestin	  domain-­‐containing	  protein	  3	  recruits	  the	  NEDD4	  E3	  
ligase	   to	  mediate	   ubiquitination	   of	   the	   β2-­‐adrenergic	   receptor.	   EMBO	  Rep	   11:605-­‐
611.	  
O’Neill	   LA,	  Bowie	  AG	   (2007)	  The	   family	  of	   five:	  TIR-­‐domain	  containing	  adaptors	   in	  Toll-­‐like	  
receptor	  signalling.	  Nat	  Rev	  Immunol	  7:353–364.	  
Parameswaran	  N,	  Pao	  CS,	  Leonhard	  KS,	  Kang	  DS,	  Kratz	  M,	  Ley	  SC,	  Benovic	  JL	  (2006)	  Arrestin-­‐
2	   and	   G	   protein-­‐coupled	   receptor	   kinase	   5	   interact	   with	   NFkappaB1	   p105	   and	  
negatively	  regulate	  lipopolysaccharide-­‐stimulated	  ERK1/2	  activation	  in	  macrophages.	  
The	  Journal	  of	  biological	  chemistry	  281:34159-­‐34170.	  
Patwari	  P,	  Emilsson	  V,	  Schadt	  EE,	  Chutkow	  WA,	  Lee	  S,	  Marsili	  A,	  Zhang	  Y,	  Dobrin	  R,	  Cohen	  
DE,	  Larsen	  PR,	  Zavacki	  AM,	  Fong	  LG,	  Young	  SG,	  Lee	  RT	  (2011)	  The	  arrestin	  domain-­‐
containing	   3	   protein	   regulates	   body	   mass	   and	   energy	   expenditure.	   Cell	   Metab	  
14:671-­‐683.	  
Porter	   KJ,	   Gonipeta	   B,	   Parvataneni	   S,	   Appledorn	   DM,	   Patial	   S,	   Sharma	   D,	   Gangur	   V,	  
Amalfitano	   A,	   Parameswaran	   N	   (2010)	   Regulation	   of	   lipopolysaccharide-­‐induced	  
inflammatory	   response	   and	   endotoxemia	   by	   beta-­‐arrestins.	   J	   Cell	   Physiol	   225:406-­‐
416.	  
Radin	  JN,	  Orihuela	  CJ,	  Murti	  G,	  Guglielmo	  C,	  Murray	  PJ,	  Tuomanen	  EI	  (2005)	  beta-­‐Arrestin	  1	  
participates	   in	   platelet-­‐activating	   factor	   receptor-­‐mediated	   endocytosis	   of	  
Streptococcus	  pneumoniae.	  Infection	  and	  immunity	  73:7827-­‐7835.	  
	   19	  
Raiborg	  C,	   Stenmark	  H	   (2009)	  The	  ESCRT	  machinery	   in	  endosomal	   sorting	  of	  ubiquitylated	  
membrane	  proteins.	  Nature	  458:445-­‐452.	  
Rauch	  S,	  Martin-­‐Serrano	   J	   (2011)	  Multiple	   Interactions	  between	   the	  ESCRT	  Machinery	  and	  
Arrestin-­‐Related	  Proteins:	  Implications	  for	  PPXY-­‐Dependent	  Budding.	  J	  Virol	  85:3546-­‐
3556.	  
Ring	   A,	   Weiser	   JN,	   Tuomanen	   EI	   (1998)	   Pneumococcal	   trafficking	   across	   the	   blood-­‐brain	  
barrier.	  Molecular	   analysis	   of	   a	   novel	   bidirectional	   pathway.	   J	   Clin	   Invest	   102:347-­‐
360.	  
Schnittler	   HJ,	   Feldmann	   H	   (2003)	   Viral	   hemorrhagic	   fever-­‐-­‐a	   vascular	   disease?	   Thromb	  
Haemost	  89:967-­‐972.	  
Seregin	   SS,	   Appledorn	   DM,	   Patial	   S,	   Bujold	  M,	   Nance	  W,	   Godbehere	   S,	   Parameswaran	   N,	  
Amalfitano	   A	   (2010)	   beta-­‐Arrestins	   modulate	   Adenovirus-­‐vector-­‐induced	   innate	  
immune	   responses:	   differential	   regulation	   by	   beta-­‐arrestin-­‐1	   and	   beta-­‐arrestin-­‐2.	  
Virus	  Res	  147:123-­‐134.	  
Shenoy	   SK,	   Lefkowitz	   RJ	   (2005)	   Seven-­‐transmembrane	   receptor	   signaling	   through	   beta-­‐
arrestin.	  Sci	  STKE	  2005:cm10.	  
Shenoy	   SK,	  McDonald	   PH,	   Kohout	   TA,	   Lefkowitz	   RJ	   (2001)	   Regulation	   of	   receptor	   fate	   by	  
ubiquitination	   of	   activated	   beta	   2-­‐	   adrenergic	   receptor	   and	   beta-­‐arrestin.	   Science	  
294:1307-­‐1313.	  
Shenoy	   SK,	   Xiao	   K,	   Venkataramanan	   V,	   Snyder	   PM,	   Freedman	   NJ,	   Weissman	   AM	   (2008)	  
Nedd4	   mediates	   agonist-­‐dependent	   ubiquitination,	   lysosomal	   targeting,	   and	  
degradation	  of	  the	  beta2-­‐adrenergic	  receptor.	  J	  Biol	  Chem	  283:22166-­‐22176.	  
Shukla	   AK,	   Xiao	   K,	   Lefkowitz	   RJ	   (2011)	   Emerging	   paradigms	   of	   b-­‐arrestindependent	   seven	  
transmembrane	  receptor	  signaling.	  Trends	  Biochem	  Sci	  36:457-­‐469.	  
	   20	  
Wang	  Y,	  Tang	  Y,	  Teng	  L,	  Wu	  Y,	  Zhao	  X,	  Pei	  G	  (2006)	  Association	  of	  beta-­‐arrestin	  and	  TRAF6	  
negatively	   regulates	   Toll-­‐like	   receptor-­‐interleukin	   1	   receptor	   signaling.	   Nature	  
immunology	  7:139-­‐147.	  
Young	  JA,	  Collier	  RJ	  (2007)	  Anthrax	  toxin:	  receptor	  binding,	  internalization,	  pore	  formation,	  
and	  translocation.	  .	  Annu	  Rev	  Biochem	  76:243–265.	  
Yu	  MC,	  Su	  LL,	  Zou	  L,	  Liu	  Y,	  Wu	  N,	  Kong	  L,	  Zhuang	  ZH,	  Sun	  L,	  Liu	  HP,	  Hu	  JH,	  Li	  D,	  Strominger	  JL,	  
Zang	   JW,	   Pei	   G,	   Ge	   BX	   (2008)	   An	   essential	   function	   for	   beta-­‐arrestin	   2	   in	   the	  
inhibitory	  signaling	  of	  natural	  killer	  cells.	  Nature	  immunology	  9:898-­‐907.	  
Zeke	   A,	   Lukacs	  M,	   Lim	  WA,	   Remenyi	   A	   (2009)	   Scaffolds:	   interaction	   platforms	   for	   cellular	  
signalling	  circuits.	  Trends	  Cell	  Biol	  19:364-­‐374.	  
	  
	  
	   	  
	   21	  








Signaling	  effect	   Reference	  
Hck	  /	  
c-­‐Fgr	  
both	   A	   Contribute	  to	  granule	  release	   (Barlic	  et	  al.	  2000)	  
	  
IkBα	  	   βarr2	   I	  (NF-­‐κB	  
pathway)	  
Prevents	  the	  phosphorylation	  
and	  degradation	  of	  IκBα	  
(Gao	  et	  al.	  2004)	  
	  




(Wang	  et	  al.	  2006)	  
	  
ND	   βarr2	   A	   Mediates	  LPS-­‐induced	  ERK	  
1/2	  activation	  
(Fan	  et	  al.	  2007)	  
	  
ND	   both	   I	   Mediate	  LPS-­‐induced	  NFκB	   (Fan	  et	  al.	  2007)	  
	  
ND	   βarr1	   A	   adenovirus-­‐vector-­‐induced	  
innate	  immune	  responses	  
(Seregin	  et	  al.	  2010)	  
	  
ND	   βarr2	   I	   adenovirus-­‐vector-­‐induced	  
innate	  immune	  responses	  
(Seregin	  et	  al.	  2010)	  
	  
P105	   βarr1	   I	   Modulates	  the	  MAP	  kinase	  
arm	  of	  TLR4	  signaling	  
(Parameswaran	  et	  al.	  2006)	  
GSK-­‐3b	   βarr2	   I	  (apoptosis)	   Stabilization	  of	  phospho-­‐GSK-­‐
3b	  (inactive	  form	  of	  GSK-­‐3b)	  
(Li	  et	  al.	  2010)	  
KIR2DL1	   βarr2 I	  (NK	  response)	   Recruitment	  of	  the	  tyrosine	  
phosphatases	  SHP-­‐1,2	  
(Yu	  et	  al.	  2008)	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Table	  II:	  βarr-­‐dependent	  pathways	  hijacked	  by	  microbes	  and	  toxins	  
βarr	  target(s)	   Pathogen	   arrestin	  
family	  
member	  
Functional	  effects	  	   Reference	  
PAF	  receptor	   Streptococcus	  
pneumoniae	  
Both	  βarrs	   activation	  of	  ERK,	  
transcyosis	  








Both	  βarrs	   Stabilize	  adhesion	  to	  
endothelial	  cells;	  open	  
anatomical	  gaps	  between	  
adjacent	  endothelial	  cells	  
(Coureuil	  et	  al.	  
2010)	  



















βarr1	   Receptor	  ubiquitination;	  
recruitment	  of	  AP-­‐1	  
adaptin	  and	  clathrin;	  
endocytosis	  




Figure	  1.	  Cellular	  pathways	  through	  which	  microorganisms	  cross	  the	  endothelia	  or	  
penetrate	  into	  the	  cytoplasm.	  	  
Extracellular	  pathogens	  may	  cross	  the	  endothelial	  monolayer	  through	  transcellular	  
penetra5on	   following	   endocytosis	   (a),	   via	   paracellular	   entry	   a<er	   disrup5on	   of	  
endothelial	   cell	   5ght	   junc5ons	   (b)	   or	   by	   transmigra5on	   with	   infected	   leukocytes	  
(Trojan	  horse	  mechanism,	  c).	  Intracellular	  pathogens	  and	  toxins	  can	  also	  penetrate	  
into	   the	   cytoplasm	   via	   endocytosis	   and	   subsequent	   crossing	   of	   endosomal	  
membranes	  (d).	  
a	   b	   c	   d	  
